An interventional study of Extracorporeal shock wave lithotripsy and Extracorporeal Shock Wave Lithotripsy combined with Tamsulosin Therapy. in Renal Stone, sponsored by Services Hospital, Lahore. Completed at 1 site in Pakistan. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2023-02-13.
Sponsored by Services Hospital, Lahore · Not applicable, Interventional, and Treatment
Extracorporeal shock wave lithotripsy (ESWL) is the least invasive and effective treatment for upper ureteric stones with a stone clearance rate of 60-90%. Tamsulosin is an alpha-blocker widely used in urological practice to relax smooth muscle of the prostate and bladder neck. Its role as part of medical expulsion therapy for the treatment of patients with kidney and ureteric stones has proved to be of considerable success. However, its role in clearing upper ureteric stones as an adjunct to ESWL is controversial. Therefore, this study will be conducted to evaluate its role in stone clearance along with extracorporeal shock wave lithotripsy in patients with upper ureteric stones
598 studies on the registry are indexed under Kidney Calculi; 163 are open to participants now.
This study's enrollment of 82 is close to the median of 90 across 461 interventional studies indexed under Kidney Calculi.
Browse Kidney Calculi studies →Services Hospital, Lahore is the lead sponsor of 33 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Extracorporeal shock wave lithotripsy will be given to the patient
Procedure: Extracorporeal shock wave lithotripsy
Extracorporeal shock wave lithotripsy combined with tamsulosin therapy will be given to the patient
Procedure: Extracorporeal Shock Wave Lithotripsy combined with Tamsulosin Therapy.
Extracorporeal shock wave lithotripsy will given to the patients
Extracorporeal Shock Wave Lithotripsy combined with Tamsulosin Therapy will be given to the patients
stone clearance
Number of patients cleared from ureteric stones
Time frame: 4 weeks
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Services Hospital, Lahore